PSAT1
Phosphoserine aminotransferase
Also known as: PSA, PSAT, SERC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y617
- Gene
- PSAT1
- Ensembl
- ENSG00000135069
- Chromosome
- 9
- Canonical length
- 370 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, and 8. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
370 residues, UniProt reviewed canonical sequence.
>Q9Y617|PSAT1
1 MDAPRQVVNF GPGPAKLPHS VLLEIQKELL DYKGVGISVL EMSHRSSDFA KIINNTENLV
61 RELLAVPDNY KVIFLQGGGC GQFSAVPLNL IGLKAGRCAD YVVTGAWSAK AAEEAKKFGT
121 INIVHPKLGS YTKIPDPSTW NLNPDASYVY YCANETVHGV EFDFIPDVKG AVLVCDMSSN
181 FLSKPVDVSK FGVIFAGAQK NVGSAGVTVV IVRDDLLGFA LRECPSVLEY KVQAGNSSLY
241 NTPPCFSIYV MGLVLEWIKN NGGAAAMEKL SSIKSQTIYE IIDNSQGFYV CPVEPQNRSK
301 MNIPFRIGNA KGDDALEKRF LDKALELNML SLKGHRSVGG IRASLYNAVT IEDVQKLAAF
361 MKKFLEMHQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 251 nTPM
Expression across tissuesHPA
Tissue
- liver: 251 nTPM
- amygdala: 154 nTPM
- kidney: 128 nTPM
- pancreas: 122 nTPM
- cerebral cortex: 120 nTPM
- basal ganglia: 116 nTPM
Single-cell type
- endometrial luminal cells: 337 nCPM
- hepatocytes: 201 nCPM
- oligodendrocytes: 111 nCPM
- ependymal cells: 110 nCPM
- astrocytes: 102 nCPM
- retinal pigment epithelial cells: 98 nCPM
Immune cell
- T-reg: 15 nTPM
- naive CD4 T-cell: 8.1 nTPM
- naive CD8 T-cell: 7.5 nTPM
- memory CD8 T-cell: 7 nTPM
- MAIT T-cell: 6 nTPM
- gdT-cell: 5.2 nTPM
Brain region
- white matter: 166 nTPM
- spinal cord: 113 nTPM
- cerebellum: 106 nTPM
- medulla oblongata: 106 nTPM
- hypothalamus: 100 nTPM
- amygdala: 91 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PSAT1.
Disease | AllUniProt
Conditions PSAT1 is implicated in, by any mechanism.
- Phosphoserine aminotransferase deficiency (PSATD) MIM:610992
- Neu-Laxova syndrome 2 (NLS2) MIM:616038
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 526 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neu-Laxova syndrome 2
- PSAT deficiency
- PSAT1-related disorder
- Neurometabolic disorder due to serine deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- identical protein binding
- pyridoxal phosphate binding
- O-phospho-L-serine:2-oxoglutarate aminotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSAT1 as an antibody target. Whether an autoantibody or antibody against PSAT1 could matter depends on whether native PSAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...